This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,223.59 firm fixed-price delivery order covers the provision of a medical product, "4566727632 ! XDEMVY 0.25% DROP 10ML", with a period of performance through January 8, 2025.
Amerisourcebergen holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.
This specific contract award was not designated with any set-aside requirements, indicating open competition. The contract supports the DLA's role in supplying critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains to military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
Generated 3/17/25, 9:52 AM